Table 2.

Univariate survival analysis and 5‐year overall survival (OS) of demographic, tumor, and treatment characteristics

		N = 100
		HR	95% CI	P‐value	5‐year OS (%)
Gender	Male	REF			80
	Female	0.43	0.13–1.4	0.16	92
Race	Caucasian	REF			87
	African American	0.60	0.08–4.7	0.63	89
	Other	1.83	0.24–14	0.56	67
	Unknown	‐	‐	‐	‐
Spanish origin	Non‐Hispanic	REF			82
	Hispanic	0.47	0.10–2.1	0.32	92
	Unknown	‐	‐	‐	‐
Insurance status	Public	REF			87
	Private	0.83	0.25–2.7	0.76	88
	None	7.5	0.87–66	0.07	50
	Unknown	0.28	0.12–4.6	0.37	75
Income	<$63,000	REF			82
	≥$63,000	0.22	0.03–1.7	0.15	96
	Unknown	‐	‐	‐	‐
Tumor size	<15 cm	REF			92
	≥15 cm	1.9	0.49–7.8	0.35	85
	Unknown	5.1	1.4–19	0.02	69
Radiation therapy	No	REF			86
	Yes	1.1	0.24–4.9	0.91	84
	Unknown	‐	‐	‐	‐
Margins	Negative	REF			95
	Positive	4.4	0.73–26	0.11	83
	Unknown	1.3	0.11–14	0.85
Treatment modality	Chemotherapy only	REF			44
	No treatment	1.27	0.25–6.6	0.775	50
	Surgery only	‐	‐	‐	‐
	Combined therapy	0.10	0.03–0.33	<0.01	92
	Unknown	‐	‐	‐	‐
Chemotherapy	No
	REF			78
	Yes	0.44	0.10–2.0	0.29	87
	Unknown	‐	‐	‐	‐
Resection type	No surgery	REF			46
	Local destruction	‐	‐	‐	‐
	Sectionectomy	0.09	0.02–0.45	0.003	93
	Hemihepatectomy	0.10	0.03–0.39	0.001	90
	Trisectionectomy	0.14	0.02–1.1	0.07	86
	Orthotopic liver transplant	‐	‐	‐	‐
	Surgery, NOS	‐	‐	‐	‐

REF, reference variable; NOS, not otherwise specified; HR, hazard ratio; CI, confidence interval; ‘‐‘, insufficient cases for analysis. P values <0.05 are shown in bold.